# Table of Contents
  * [1.1   Materials and Methods](001_1_1___Materials_and_Methods\001_1_1___Materials_and_Methods.md)
    * [1.1.1 Modelling strategy](001_1_1___Materials_and_Methods\001_1_1_1_Modelling_strategy\001_1_1_1_Modelling_strategy.md)
    * [1.1.2 Data used](001_1_1___Materials_and_Methods\002_1_1_2_Data_used\002_1_1_2_Data_used.md)
    * [1.1.3 Model parameters and assumptions](001_1_1___Materials_and_Methods\003_1_1_3_Model_parameters_and_assumptions\003_1_1_3_Model_parameters_and_assumptions.md)
  * [1.2   Results and Discussion](002_1_2___Results_and_Discussion\002_1_2___Results_and_Discussion.md)
    * [1.2.1 Raltegravir final PK parameter tables](002_1_2___Results_and_Discussion\001_1_2_1_Raltegravir_final_PK_parameter_tables\001_1_2_1_Raltegravir_final_PK_parameter_tables.md)
    * [1.2.2: Raltegravir Diagnostics Plots](002_1_2___Results_and_Discussion\002_1_2_2__Raltegravir_Diagnostics_Plots\002_1_2_2__Raltegravir_Diagnostics_Plots.md)
    * [1.2.3: Raltegravir Concentration-Time profiles](002_1_2___Results_and_Discussion\003_1_2_3__Raltegravir_Concentration-Time_profiles\003_1_2_3__Raltegravir_Concentration-Time_profiles.md)
  * [1.3   Conclusion](003_1_3___Conclusion\003_1_3___Conclusion.md)
  * [References](004_References\004_References.md)
